See more : Argo Yachts Development Co.,Ltd. (7566.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Kerala Ayurveda Limited (KERALAYUR.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kerala Ayurveda Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Monadelphous Group Limited (MOPHY) Income Statement Analysis – Financial Results
- Rhinomed Limited (RHNMF) Income Statement Analysis – Financial Results
- BioLineRx Ltd. (BLRX) Income Statement Analysis – Financial Results
- Custodian REIT Plc (CREI.L) Income Statement Analysis – Financial Results
- Net One Systems Co., Ltd. (NONEF) Income Statement Analysis – Financial Results
Kerala Ayurveda Limited (KERALAYUR.BO)
About Kerala Ayurveda Limited
Kerala Ayurveda Ltd. engages in the manufacture and sale of holistic healing and wellness products and healthcare services. The firm's ayurvedic solutions include lifestyle products such as health supplements, skin and beauty care products and specialty food. It also operates wellness centers and clinics and ayurvedic academies. The company was founded by Kollasseril Govindan Kunju Panicker in 1945 and is headquartered in Bengaluru, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.02B | 892.38M | 762.73M | 618.66M | 761.77M | 618.90M | 588.72M | 504.13M | 459.48M | 390.28M | 348.52M | 312.36M | 342.55M | 260.91M | 328.38M | 445.17M |
Cost of Revenue | 575.67M | 200.50M | 171.69M | 153.27M | 153.76M | 139.30M | 114.81M | 112.68M | 116.99M | 92.83M | 69.17M | 59.51M | 95.22M | 57.54M | 138.14M | 212.43M |
Gross Profit | 447.69M | 691.88M | 591.04M | 465.39M | 608.01M | 479.60M | 473.91M | 391.44M | 342.49M | 297.45M | 279.34M | 252.84M | 247.34M | 203.37M | 190.25M | 232.74M |
Gross Profit Ratio | 43.75% | 77.53% | 77.49% | 75.23% | 79.82% | 77.49% | 80.50% | 77.65% | 74.54% | 76.22% | 80.15% | 80.95% | 72.20% | 77.95% | 57.93% | 52.28% |
Research & Development | 7.56M | 3.62M | 1.16M | 750.00K | 616.83K | 381.51K | 309.75K | 342.51K | 234.66K | 772.09K | 464.04K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 70.62M | 62.39M | 46.41M | 36.19M | 25.60M | 22.61M | 25.12M | 19.74M | 15.40M | 8.42M | 5.39M | 0.00 | 0.00 | 58.85M | 47.32M | 97.68M |
Selling & Marketing | 105.84M | 106.51M | 72.73M | 58.53M | 67.63M | 38.45M | 31.60M | 19.44M | 21.35M | 17.65M | 30.46M | 0.00 | 0.00 | 32.67M | 34.02M | 52.37M |
SG&A | 176.46M | 249.01M | 119.14M | 94.72M | 93.23M | 61.06M | 56.72M | 39.18M | 36.75M | 26.07M | 35.85M | 0.00 | 0.00 | 91.52M | 81.34M | 150.05M |
Other Expenses | 215.62M | 2.87M | 3.46M | 776.00K | 198.00K | 414.44K | -2.11M | -2.35M | -2.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 399.65M | 680.47M | 509.23M | 421.66M | 536.78M | 440.77M | 402.08M | 335.46M | 291.04M | 249.78M | 255.67M | 244.69M | 260.00M | 248.64M | 205.35M | 332.42M |
Cost & Expenses | 975.32M | 880.97M | 680.91M | 574.93M | 690.54M | 580.07M | 516.89M | 448.15M | 408.03M | 342.61M | 324.85M | 304.20M | 355.22M | 306.18M | 343.48M | 544.86M |
Interest Income | 1.64M | 768.00K | 2.55M | 346.00K | 197.94K | 1.27M | 2.64M | 1.45M | 705.72K | 366.01K | 37.86K | 62.00K | 219.54K | 135.42K | 103.46K | 70.99K |
Interest Expense | 44.64M | 48.22M | 65.20M | 63.22M | 15.47M | 24.28M | 18.66M | 12.24M | 12.95M | 16.37M | 9.47M | 9.77M | 9.81M | 10.55M | 23.26M | 35.64M |
Depreciation & Amortization | 13.43M | 11.08M | 12.02M | 12.78M | 11.43M | 9.82M | 18.32M | 17.75M | 18.97M | 10.60M | 9.64M | 10.49M | 10.19M | 15.12M | 24.13M | 17.84M |
EBITDA | 70.79M | 57.42M | 106.72M | 8.62M | 73.78M | 66.54M | 83.35M | 73.81M | 73.91M | 59.57M | 40.92M | 30.42M | 8.26M | -12.23M | 19.47M | -75.12M |
EBITDA Ratio | 6.92% | 2.84% | 12.76% | 1.39% | 9.49% | 8.45% | 13.36% | 14.24% | 16.09% | 15.27% | 10.89% | 9.74% | 2.41% | -21.37% | 3.45% | -15.14% |
Operating Income | 48.05M | 50.08M | 98.65M | 8.87M | 71.23M | 38.83M | 71.83M | 42.50M | 41.08M | 31.74M | 17.47M | 425.00K | -19.04M | -16.00M | -40.55M | -131.57M |
Operating Income Ratio | 4.69% | 5.61% | 12.93% | 1.43% | 9.35% | 6.27% | 12.20% | 8.43% | 8.94% | 8.13% | 5.01% | 0.14% | -5.56% | -6.13% | -12.35% | -29.55% |
Total Other Income/Expenses | -35.34M | -55.66M | -70.60M | -111.12M | -25.86M | -7.85M | -30.17M | -14.19M | -10.37M | -15.93M | 2.00 | -6.52M | 0.00 | 32.94M | 1.00 | 0.00 |
Income Before Tax | 12.71M | -5.59M | 28.05M | -67.38M | 45.38M | 30.98M | 41.66M | 41.79M | 41.08M | 31.74M | 17.47M | 1.64M | -19.04M | -16.00M | -40.55M | -131.57M |
Income Before Tax Ratio | 1.24% | -0.63% | 3.68% | -10.89% | 5.96% | 5.01% | 7.08% | 8.29% | 8.94% | 8.13% | 5.01% | 0.53% | -5.56% | -6.13% | -12.35% | -29.55% |
Income Tax Expense | 21.34M | -1.31M | 4.11M | -18.95M | 4.84M | 5.75M | 12.87M | 9.00M | 13.71M | 6.59M | 8.28M | 6.58M | 1.77M | 6.33M | -3.59M | -10.32M |
Net Income | -15.27M | -9.01M | 23.61M | -48.44M | 38.97M | 24.45M | 28.08M | 30.59M | 27.01M | 23.56M | 7.44M | -6.08M | -21.42M | -22.57M | -38.04M | -121.41M |
Net Income Ratio | -1.49% | -1.01% | 3.10% | -7.83% | 5.12% | 3.95% | 4.77% | 6.07% | 5.88% | 6.04% | 2.13% | -1.94% | -6.25% | -8.65% | -11.58% | -27.27% |
EPS | -1.38 | -0.85 | 2.24 | -4.59 | 3.69 | 2.32 | 2.66 | 2.90 | 2.56 | 2.23 | 0.70 | -0.58 | -2.03 | -2.14 | -3.50 | 0.00 |
EPS Diluted | -1.38 | -0.85 | 2.24 | -4.59 | 3.69 | 2.32 | 2.66 | 2.90 | 2.56 | 2.23 | 0.70 | -0.58 | -2.03 | -2.14 | -3.50 | 0.00 |
Weighted Avg Shares Out | 11.04M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.55M | 10.56M | 10.87M | 0.00 |
Weighted Avg Shares Out (Dil) | 11.04M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.56M | 10.55M | 10.56M | 10.87M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports